A 1-year study of drug prescriptions and adverse drug reactions in psychiatric hospital practice

Pharmacoepidemiology and Drug Safety

Volumn 5, Issue 6, 1996, Pages 377-384

  Cosentino, Marco ^a   Leoni, Olivia ^a   Rispoli, Laura ^b   Pellegrini, Carlo ^b   Finavera, Lucio ^b   Lecchini, Sergio ^a   Frigo, Gianmario ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b Psychiatric Unit   (Italy)

Author keywords

adverse drug reactions; adverse events; drug surveillance; drug utilization; psychiatric hospitals

Indexed keywords

PSYCHOTROPIC AGENT;

ADVERSE DRUG REACTION; ARTICLE; DATA BASE; DRUG MONITORING; DRUG USE; HUMAN; MENTAL HOSPITAL; MENTAL PATIENT; PHARMACOEPIDEMIOLOGY; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0030499297     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199611)5:6<377::AID-PDS242>3.0.CO;2-F     Document Type: Article

References (37)

1. Joint Commission Dialogue. Monitoring and reporting adverse drug reactions. American Journal of Hospital Pharmacy 1989; 46: 65-66.
2. Tse, C. S. T. and Madura, A. J. An adverse drug reaction reporting program in a community hospital. Quality Review Bulletin 1988; 14: 336-340.
3. Carson, J. L., Strom, B. L. and Maislin, G. Screening for unknown effects of newly marketed drugs. In: Pharmacoepidemiology. Strom, B. L. (Ed.) John Wiley & Sons Ltd, Chichester, 1994, pp. 431-447.
4. Prien, R. F., Haber, P. A. and Caffey, E. M. Jr. The use of psychoactive drugs in elderly patients with psychiatric disorders: survey conducted in twelve Veterans Administration hospitals. Journal of the American Geriatrics Society 1975; 23: 104-112.
5. Hemminki, E. Polypharmacy among psychiatric patients. Acta Psychiatrica Scandinavica 1977; 56: 347-356.
6. Yosselson-Superstine, S., Sternik, D. and Liebenzon, D. Prescribing patterns in psychiatric hospitals in Israel. Acta Psychiatrica Scandinavica 1979; 58: 477-482.
7. Swett, C. Jr. Patterns of drug use in psychiatric inpatient wards. Journal of Clinical Psychiatry 1979; 40; 464-468.
8. Laska, E., Craig, T. J., Siegel, C. and Wanderling, J. Long-term monitoring of psychopharmacological treatment in hospitalized patients. In: Epidemiological Impact of Psychotropic Drugs. Tognoni, G., Bellantuono, C. and Lader, M. (Eds) Elsevier, Amsterdam, 1981, pp. 101-116.
9. Michel, K. and Kolakowska, T. A survey of prescribing psychotropic drugs in two psychiatric hospitals. British Journal of Psychiatry 1981; 138: 217-221.
10. James, D. H. Monitoring drugs in hospitals for the mentally handicapped. British Journal of Psychiatry 1983; 142: 163-165.
11. Edwards, S. and Kumar, V. A survey of prescribing of psychotropic drugs in a Birmingham psychiatric hospital. British Journal of Psychiatry 1984; 145: 502-507.
12. Morgan, R. and Gopalaswamy, A. K. Psychotropic drugs: another survey of prescribing patterns. British Journal of Psychiatry 1984; 144: 298-302.
13. Wilson, W. H., Ban, T. A. and Guy, W. Pharmacotherapy of chronic hospitalized schizophrenics: prescription practices. Neuropsychobiology 1985; 14: 75-82.
14. Clark, A. F. and Holden, N. L. The persistence of prescribing habits: a survey and follow-up of prescribing to chronic hospital in-patients. British Journal of Psychiatry 1987; 150: 88-91.
15. Muijen, M. and Silverstone, T. A comparative hospital survey of psychotropic drug prescribing. British Journal of Psychiatry 1987; 150: 501-504.
16. Wressell, S. E., Tyrer, S. P. and Berney, T. P. Reduction in antipsychotic drug dosage in mentally handicapped patients. A hospital study. British Journal of Psychiatry 1990; 157: 101-106.
17. Grohmann, R., Hippius, H., Müller-Oerlinghausen, B., et al. Assessment of adverse drug reactions in psychiatric hospitals. European Journal of Clinical Pharmacology 1984; 26: 727-734.
18. Grohmann, R., Koch, R. and Schmidt, L. G. Extrapyramidal symptoms in neuroleptic recipients. Agents and Actions Supplements 1990; 29: 71-82.
19. Schmidt, L. G., Grohmann, R., Helmchen, H., et al. Adverse drug reactions. An epidemiological study at psychiatric hospitals. Acta Psychiatrica Scandinavica 1984; 70: 77-89.
20. Crepet, P. A transition period in psychiatric care in Italy ten years after the reform. British Journal of Psychiatry 1990; 156: 27-36.
21. Bellantuono, C., Reggi, V., Tognoni, G., et al. Comparison of practice in hospitals and community mental health centers. In: Epidemiological Impact of Psychotropic Drugs. Tognoni, G., Bellantuono, C. and Lader, M. (Eds) Elsevier, Amsterdam, 1981, pp. 101-116.
22. WHO Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) Classification Index Including Defined Daily Doses (DDDs) for Plain Substances. WHO, Oslo, 1994.
23. Maistrello, I., Morgutti, M., Maltempi, M. and Dantes, M. Adverse drug reactions in hospitalized patients: an operational procedure to improve reporting and investigate underreporting. Pharmacoepidemiology and Drug Safety 1995; 4: 101-106.
24. WHO Collaborating Centre for International Drug Monitoring, Uppsala, Sweden. 14th Annual Meeting of Participating National Centres, Barcelona, September 30-October 1, 1991.
25. World Health Organisation Adverse Reaction Dictionary. WHO, Uppsala, 1993.
26. Dukes, M. N. G. (Ed.) Meyler's Side Effects of Drugs, 12th edn. Elsevier, Amsterdam, 1992.
27. Gosney, M. and Tallis, R. Prescription of contra-indicated and interacting drugs in elderly patients admitted to hospital. Lancet 1984; i: 564-567.
28. Ayd, F. J. Jr. Rational pharmacotherapy: once-a-day drug dosage. Diseases of the Nervous System 1973; 34: 371-378.
29. Levinson, F. D. Pharmacologic treatment of schizophrenia. Clinical Therapeutics 1991; 13: 326-352.
30. Johnson, D. A. W. and Wright, N. F. Drug prescribing for schizophrenic out-patients on depot injections. Repeat surveys over 18 years. British Journal of Psychiatry 1990; 156: 827-834.
31. Orlov, P., Kasparian, G., DiMascio, A. and Cole, J. O. Withdrawal of antiparkinson drugs. Archives of General Psychiatry 1971; 25: 410-412.
32. Klett, C. J., Point, P. and Caffey, E. Jr. Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics. Archives of General Psychiatry 1972; 26: 374-379.
33. McClelland, H. A., Blessed, G., Bhate, S., Ali, N. and Clarke, P. A. The abrupt withdrawal of antiparkinsonian drugs in schizophrenic patients. British Journal of Psychiatry 1974; 124: 151-159.
34. Carter, G. The abrupt withdrawal of antiparkinsonian drugs in mentally handicapped patients. British Journal of Psychiatry 1983; 142: 166-168.
35. Johnson, D. A. W. Prevalence and treatment of drug induced extrapyramidal symptoms. British Journal of Psychiatry 1978; 132: 27-30.
36. Simpson, G. M., Pi, E. H. and Sramek, J. J. Jr. Management of tardive dyskinesia: current update. Drugs 1982; 23: 381-393.
37. Bigby, M., Jick, S., Jick, H. and Arndt, K. Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15438 consecutive inpatients, 1975 to 1982. Journal of the American Medical Association 1986; 256: 3358-3363.